<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig5">
 <label>Fig. 5</label>
 <caption>
  <p>Meta-analysis of 
   <italic>SORL1-38b</italic> expression in non-AD and AD cerebellum. 
   <bold>a</bold> TaqMan qPCR assay using a probe designed for detection of 
   <italic>SORL1-38b</italic> transcripts shows a 2.0-fold reduction in expression levels in AD cerebellum compared to non-AD controls from a Mayo Clinic cohort (non-AD; N = 25, AD; N = 25). 
   <bold>b</bold> qPCR analysis on non-AD and AD cerebellum from UW cohort confirms reduction of 
   <italic>SORL1-38b</italic> in AD samples (non-AD; N = 6; AD; N = 14). 
   <bold>c</bold> Meta-analysis including expression levels of 
   <italic>SORL1-38b</italic> in non-AD versus AD cerebella from Mayo Clinic and UW cohorts. 
   <bold>d</bold>–
   <bold>f</bold> Relative expression of 
   <italic>SORL1-38b</italic> to the genotype of SNP24 located in the 3′ haplotype of 
   <italic>SORL1</italic> (rs2282649) in Mayo Clinic (
   <bold>d</bold>; non-AD; N = 23, AD; N = 12), UW cohort (
   <bold>e</bold>; non-AD; N = 6; AD; N = 14), and meta-analysis including data from both cohorts (
   <bold>f</bold>)
  </p>
 </caption>
 <graphic xlink:href="40478_2021_1140_Fig5_HTML" id="MO5" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
